First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors.
R. Galot
Z. Castel-Ajgal
N. Kotecki
C. Jungels
J. Delord
I. Korakis
Samira El-Farouk
Claire Jouffroy-Zeller
A. Quesnel
Carolina Duarte
A. Taamma
T. Maurin
Lola Lecru
Antoine Mousson
Orphée Blanchard
Anne-Laure Blayo
N. Lenne
S. Schann
Xavier Leroy
J. Cuillerot
C. le Tourneau
J. Machiels
Medicine